NCT05341713View on ClinicalTrials.gov

Epileptic Seizure in Epilepsy Patients After SARS-CoV-2 Vaccination

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
Epileptic Seizures Related to DrugsSARS-CoV-2 Acute Respiratory DiseaseVaccine Adverse Reaction
Interventions
BIOLOGICAL

inactive SARS-Cov-2 vaccine

We included epilepsy patients who were vaccinated with inactive SARS-CoV-2 vaccines

Trial Locations (1)

710000

Xijing Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT05341713 - Epileptic Seizure in Epilepsy Patients After SARS-CoV-2 Vaccination | Biotech Hunter | Biotech Hunter